| Health / Medical Topics |
Prostate Cancer Vaccine ONY-P1
A cell-based vaccine derived from prostate cancer with potential immunopotentiating and antineoplastic activities. Prostate cancer vaccine ONY-P1 is derived from three irradiated allogeneic prostate cancer cell lines that represent different stages of prostate cancer and express a broad range of prostate and prostate cancer antigens. Upon administration, this vaccine may stimulate a host immune response against prostate cancer cells; in the vaccination schedule, the first two vaccinations are co-administered with bacillus Calmette-Guerin (BCG) as an adjuvant. (NCI Thesaurus)
YOU MAY ALSO LIKE
A finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v6 classification system.
Prostate cancer with tumor invading the rectum, levator muscles, and/or pelvic wall. (from AJCC 7th Ed.)
A phase III, randomized, placebo-controlled cancer prevention trial of >18,000 men coordinated by the Southwest Oncology Group. The trial will determine…
The identification of key molecular alterations in prostate-cancer cells implicates carcinogen defenses (GSTP1), growth-factor-signaling pathways (NKX3.1, PTEN, and p27), and androgens (AR)…
A pathologic finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v6 classification system. TNM…
A pathologic finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v6 classification system as…
